Planta Medica International Open 2017; 4(S 01): S1-S202
DOI: 10.1055/s-0037-1608457
Poster Session
Georg Thieme Verlag KG Stuttgart · New York

Protective effect of Lagerstroemia speciosa against dextran sulfate sodium induced ulcerative colitis in C57BL/6 mice

S subramanya
3   Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates
,
G Chaudhary
1   Department of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Dhule, India
,
U Mahajan
1   Department of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Dhule, India
,
S Goyal
1   Department of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Dhule, India
,
S ojha
2   Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, Al Ain, United Arab Emirates
,
C Patil
1   Department of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Dhule, India
› Author Affiliations
Further Information

Publication History

Publication Date:
24 October 2017 (online)

 

The protective effect of methanolic extract of Lagerstroemia speciosaleaves (LS) was evaluated against dextran sulfate sodium (DSS) induced ulcerative colitis in C57BL/6 mice. The administration of DSS (2.5% in drinking water ad libitum) in C57BL/6 mice induced ulcerative colitis in 7 days. The LS was orally administered for 7 days at daily doses of 100 and 200 mg/kg. At the end of 7 days of treatment the animals were sacrificed, colonic tissues were removed and processed for further analysis of oxidative stress, and histopathology. In DSS treated mice the oxidative stress markers were elevated compared to controls. There was also significant reduction in the anti-oxidant defense levels marked by reduced cellular glutathione, catalase, and superoxide dismutase. The DSS-induced damage to the colon epithelium was evident from a significant increase in the lipid peroxidation. The histology of colon sections revealed inflammatory changes and marked impairment in the integrity of the mucosal lining with inflammatory changes. Both the doses of LS significantly prevented DSS-induced inflammatory and ulcerative damages of the colon, reduced lipid peroxidation and also restored the levels of innate antioxidants in the colon tissue. These findings indicate the protective effects of LS against the DSS-induced inflammatory and oxidative damage in the mouse colon. Further investigation involving bioactivity guided fractionation of the LS can yield potent constituent which may have a significant role in the treatment of inflammatory bowel disease and ulcerative colitis.